Use of cookies

Lund University uses cookies to ensure that the website functions properly and to improve your experience.

Read more in our cookie policy

Search results

Filter

Reset filter

Filetype

Your search for "*" yielded 569674 hits

Collaborators

  National Annika Karlsson - Department of Laboratory Medicine, Karolinska Institutet Fredrik Månsson   - Department of Translational Medicine, Lund University Gülsen Özkaya Sahin -  Region Skåne , Department of Laboratory Medicine, Section of Clinical Microbiology; Department of Translational Medicine, Lund University Hans Norrgren - Division of Infection Medicine, Lund University Joakim Esbjörns

https://www.virology.lu.se/hiv-host-interactions/collaborators - 2026-11-01

Contact

Joakim Esbjörnsson, PhD Associate Professor in Virology Senior Lecturer in Medical Microbiology Head of Systems Virology Group Department of Translational Medicine Faculty of Medicine Lund University Postal address: Lund University BMC, B13 221 84 Lund Sweden Phone: +46 46 22 20119, Office email:  joakim [dot] esbjornsson [at] med [dot] lu [dot] se (joakim[dot]esbjornsson[at]med[dot]lu[dot]se)   H

https://www.virology.lu.se/systems-virology/contact - 2026-11-01

The Systems Virology team

      Joakim Esbjörnsson   Associate Professor   Ph.D. Virology    Read about Joakim in the Research Portal   Joakim's publications " The overarching aim of my research is to understand the key mechanisms of HIV transmission and the rate of disease pathogenesis. I am particularly interested in the virus-host interactions that take place when HIV establishes infection, and how HIV-2 can be used as

https://www.virology.lu.se/systems-virology/systems-virology-team - 2026-11-01

Clinical Virology

The focus of the clinical virology team is to develop and further improve diagnostic tools for detection and quantification of viral infections, including next-generation sequencing approaches in the field of “pandemic preparedness”. Our current work in the field involves many collaborators, the establishment of biobanks and the use of clinical and environmental specimens in our investigations. Du

https://www.virology.lu.se/clinical-virology - 2026-11-01

Lund University Virus Centre

Vision We want to create a regionally, nationally and internationally well-known center for translational virus research at the highest level where experimental and clinical research meet in synergy. Lund University Virus Centre   Pandemics and alertness The Covid-19 pandemic has clearly demonstrated how fast viruses can become a significant threat to global health. Through national and internatio

https://www.virology.lu.se/lund-university-virus-centre - 2026-11-01

Molecular Virology

Human papillomavirus (HPV) infections cause 500.000 cases of cervical cancer each   year in the world (400 cases in Sweden), and 250.000 deaths (120 cases in Sweden).   HPV16 is the most common cancer-associated HPV type. The majority of all HPV16   infections is cleared by the host but a fraction persists that may cause cancer. The full   life cycle of HPV16 requires cell proliferation at the ear

https://www.virology.lu.se/molecular-virology - 2026-11-01

Joakim Esbjörnsson, Ph.D.

Principal Investigator, Associate Professor in Virology “What would be easy turned out to be difficult. That is one way of summarising over 30 years of efforts to find a vaccine or a cure for HIV, the virus that causes the disease AIDS. It is this scientific challenge that triggers the researcher Joakim Esbjörnsson.” From “Forskarnas Nyheter”(2017) Joakim Esbjörnsson is an Associate senior lecture

https://www.virology.lu.se/systems-virology/joakim-esbjornsson-phd - 2026-11-01

Pandemics and alertness

The Covid-19 pandemic has clearly demonstrated how fast viruses can become a significant threat to global health. Through national and international collaboration, we can improve our readiness for future virus outbreaks. Pandemics and alertness | Lund University LinkedIn_Pandemics_and alertness

https://www.virology.lu.se/pandemics-and-alertness - 2026-11-01

Tumor Virology

The field of tumor virology has provided groundbreaking insights into the causes of human cancer. In my research at Lund University I focus on I) characterization of human papillomavirus (HPV)-associated mechanisms for disease development and II) use of HPV for prevention of disease. Concerning HPV-associated benign tumors as recurrent laryngeal papilloma, we study de-regulated pathways of the loc

https://www.virology.lu.se/tumor-virology - 2026-11-01

Projects

Laryngeal Papilloma  Interaction between HPV, respiratory bacteria, and a dysfunctional local immune response may promote laryngeal papilloma.    Although presence of human papillomavirus (HPV)-vaccines, there are new cases of HPV-diseases. Such a disease is laryngeal papilloma (LP) which is a benign tumor that can persist during life and is considered incurable, manifested by obstruction in the r

https://www.virology.lu.se/tumor-virology/projects - 2026-11-01

Ola Forslund (PI)

Principal Investigator, Associate Professor in Virology Ola Forslund is a Senior Lecturer in Tumor Virology and Associate Professor in Virology at the Department of Translational Medicine, Medical Faculty at Lund University.  Ola received his Ph.D in 1997 at Lund University, and performed postdoctoral studies at Umeå University and as a visiting research fellow at IMVS in Adelaide. From 2000 he wa

https://www.virology.lu.se/tumor-virology/ola-forslund-pi - 2026-11-01